background
upper
respiratori
tract
viral
infect
caus
asthma
exacerb
children
howev
impact
natur
cold
children
asthma
commun
particularli
highrisk
urban
environ
less
well
defin
object
hypothes
children
highsymptom
upper
respiratori
viral
infect
reduc
airway
function
greater
respiratori
tract
inflamm
children
virusposit
lowsymptom
ill
virusneg
upper
respiratori
tract
symptom
method
studi
children
asthma
detroit
michigan
schedul
surveil
period
selfreport
respiratori
ill
year
symptom
score
spirometri
fraction
exhal
nitric
oxid
feno
nasal
aspir
biomark
viral
nucleic
acid
rhinoviru
rv
copi
number
assess
result
aspir
collect
surveil
sampl
respiratori
ill
virusposit
compar
virusneg
asymptomat
condit
children
sever
cold
symptom
score
show
reduc
forc
expiratori
flow
pulmonari
volum
fef
higher
nasal
messeng
rna
express
cxc
motif
chemokin
ligand
cxcl
melanoma
differentiationassoci
protein
higher
protein
abund
cc
motif
chemokin
ligand
ccl
children
mild
symptom
score
asymptomat
infect
show
normal
airway
function
fewer
biomark
elev
virusneg
coldlik
ill
demonstr
increas
feno
minim
biomark
elev
normal
airflow
rv
copi
number
associ
nasal
chemokin
level
symptom
score
conclus
urban
children
asthma
highsymptom
respiratori
viral
infect
reduc
fef
elev
nasal
biomark
children
mild
symptomat
infect
virusneg
ill
viral
infect
common
caus
asthma
exacerb
children
crosssect
studi
outpati
children
sick
asthma
exacerb
shown
posit
viral
infect
compar
children
well
rhinoviru
rv
make
virus
isol
viral
detect
associ
asthma
exacerb
treatment
failur
nevertheless
appar
well
children
asthma
may
also
harbor
respiratori
virus
airway
twentyon
percent
hospit
children
year
older
without
wheez
test
posit
viru
similarli
children
year
age
older
wellcontrol
asthma
test
posit
viru
viru
detect
rate
healthi
children
higher
young
children
develop
commun
given
high
rate
rv
transmiss
within
famili
durat
rv
shed
infect
asymptomat
infect
like
repres
children
convalesc
symptomat
viral
infect
impact
respiratori
viral
detect
children
asthma
commun
environ
less
well
studi
children
madison
wisconsin
virusposit
week
associ
greater
asthma
symptom
well
frequent
loss
asthma
control
commun
cohort
children
asthma
randrick
australia
suburb
sydney
rv
detect
nasal
sampl
associ
increas
cough
phlegm
wheez
chest
tight
chang
peak
expiratori
flow
pef
forc
expiratori
volum
second
fev
seen
howev
effect
natur
respiratori
viral
infect
lung
function
symptom
urban
children
asthma
remain
larg
undefin
pattern
viral
respiratori
ill
may
differ
urban
suburban
children
exampl
sick
innerc
infant
lower
rate
viral
detect
suburban
infant
addit
asthma
undertr
urban
children
may
amplifi
effect
viral
infect
final
wherea
other
examin
nasal
cytokin
respons
children
asthma
natur
cold
potenti
effect
asymptomat
mild
viral
infect
studi
hypothes
children
asthma
urban
commun
environ
experi
highsymptom
upper
respiratori
viral
infect
reduc
pulmonari
function
well
greater
respiratori
tract
inflamm
viral
copi
number
children
virusposit
lowsymptom
ill
virusneg
upper
respiratori
tract
symptom
therefor
examin
influenc
viral
infect
respiratori
symptom
lung
function
nasal
cytokin
children
asthma
detroit
michigan
studi
conduct
commun
action
asthma
caaa
communitybas
participatori
research
partnership
part
environment
epidemiolog
studi
evalu
impact
roadwayassoci
air
pollut
asthma
health
children
known
probabl
asthma
live
detroit
michigan
recruit
use
screen
questionnair
distribut
commun
venu
doortodoor
recruit
neighborhood
near
highway
questionnair
ask
demograph
inform
symptom
whether
child
ever
diagnos
medic
care
provid
follow
condit
asthma
bronchiti
bronchiol
reactiv
airway
diseas
pneumonia
parent
also
ask
whether
child
taken
prescript
medic
condit
classif
asthma
sever
base
symptom
frequenc
report
inhal
steroid
use
etabl
children
classifi
atop
report
hay
fever
nasal
allergi
eczema
studi
approv
univers
michigan
irb
id
fiftythre
children
particip
surveil
assess
period
health
statu
season
fall
summer
surveil
period
staff
obtain
spirometri
symptom
report
nasal
lavag
sampl
home
visit
respiratori
symptom
assess
use
modifi
version
previous
publish
respiratori
symptom
score
assess
fever
cough
sore
throat
nasal
symptom
wheez
difficulti
breath
interfer
activ
etabl
definit
children
wheez
difficulti
breath
breath
fast
symptom
score
greater
famili
given
calendar
respiratori
symptom
scale
mark
level
symptom
winter
summer
measur
repeat
period
whenev
child
experienc
symptomat
respiratori
ill
defin
symptom
score
higher
refer
sick
period
set
low
symptom
threshold
maxim
sensit
detect
viral
ill
famili
call
child
becam
ill
symptom
reach
appropri
threshold
staff
would
begin
sick
period
assess
within
hour
phone
call
median
time
first
sampl
hour
symptom
develop
staff
also
conduct
weekli
telephon
call
identifi
ill
progress
famili
may
report
initi
sick
period
collect
child
current
symptom
nasal
lavag
sampl
collect
time
surveil
period
sick
period
field
staff
two
squirt
isoton
nacl
bf
ascher
lenexa
kansa
instil
child
nostril
subject
blew
nose
zipper
plastic
bag
ml
viral
transport
medium
remel
lenexa
kansa
ad
collect
sampl
place
transport
cooler
transport
henri
ford
health
system
epidemiolog
lab
freez
subsequ
transport
ann
arbor
dri
ice
nasal
lavag
sampl
homogen
thermo
fisher
scientif
waltham
massachusett
nucleic
acid
extract
use
trizol
thermofish
chloroform
rneasi
mini
kit
qiagen
valencia
california
sampl
analyz
viral
nucleic
acid
multiplex
polymeras
chain
reaction
pcr
seegen
seeplex
ace
detect
kit
concord
california
kit
detect
human
adenoviru
bocaviru
coronavirus
enteroviru
influenza
b
metapneumoviru
parainfluenza
virus
respiratori
syncyti
viru
rsv
b
rhinoviru
b
c
surveil
sampl
specimen
analyz
viru
cold
sampl
specimen
sick
week
pool
viral
detect
analysi
sampl
sick
period
pool
cytokin
viral
copi
number
determin
nasal
sampl
analyz
messeng
rna
mrna
protein
complementari
dna
cdna
synthes
total
rna
taqman
revers
transcriptas
kit
qiagen
dna
digest
dnase
qiagen
cxc
motif
chemokin
ligand
cxcl
interferon
regulatori
factor
retinoicacidinduc
protein
rigi
melanoma
differentiationassoci
protein
tolllik
receptor
interferon
ifn
mrna
express
measur
quantit
polymeras
chain
reaction
qpcr
specif
primer
probe
span
exonexon
junction
intron
splicesit
use
prevent
amplif
genom
dna
express
level
normal
glyceraldehyd
dehydrogenas
gapdh
use
ddct
method
reaction
gapdh
cycl
number
greater
analyz
interleukin
il
protein
level
determin
multiplex
immun
assay
affymetrix
santa
clara
california
biomark
chosen
base
previou
studi
show
elev
rv
infect
interest
examin
biomark
previous
studi
difficulti
detect
biomark
cytokin
nasal
aspir
fluid
cost
avail
sampl
test
posit
rv
copi
number
determin
qpcr
use
previous
publish
primer
rhinovirusposit
surveil
sampl
sampl
rvposit
sick
period
analyz
determin
rv
genotyp
rhinoviru
type
perform
seminest
pcr
amplif
region
gelpurifi
pcr
product
ident
sequenc
determin
comparison
known
sequenc
use
blast
http
blastncbinlm
nihgovblastcgi
use
protocol
develop
largescal
communitybas
asthma
studi
staff
conduct
spirometri
assess
lung
function
home
visit
use
easyon
spiromet
ndd
andov
massachusett
fraction
exhal
nitric
oxid
exhal
breath
feno
measur
use
niox
mino
aerocrin
new
provid
new
jersey
initi
analysi
identifi
addit
anticip
viralposit
ill
virusneg
asymptomat
period
surveil
sampl
virus
detect
symptomat
ill
seen
viru
detect
prompt
us
perform
posthoc
analysi
look
similar
differ
group
viruspositivesever
symptom
symptom
score
virusnegativemild
symptom
symptom
score
virusnegativeasymptomat
symptom
score
virusneg
sever
symptom
symptom
score
viruspositivemild
symptom
symptom
score
viruspositiveasymptomat
symptom
score
mean
standard
deviat
use
describ
nasal
biomark
protein
level
nasal
mrna
level
symptom
score
viral
ill
distribut
continu
outcom
variabl
examin
appropri
transform
taken
achiev
normal
tolllik
receptor
mrna
level
undetect
larg
number
sampl
etabl
therefor
result
analyz
binari
variabl
detect
undetect
effect
viralsymptom
state
individu
symptom
lung
function
nasal
aspir
mrna
protein
level
rv
copi
number
determin
use
gener
estim
equat
gee
exchang
correl
structur
use
identifi
link
continu
outcom
log
link
binari
one
analysi
perform
use
sa
softwar
cari
north
carolina
evalu
adjust
age
sex
ethnicityrac
selfreport
atopi
smoker
home
caregiv
educ
attain
season
sampl
collect
whether
sampl
surveil
sick
collect
period
famili
incom
proxim
hightraff
highway
baselin
asthma
sever
medic
use
evalu
includ
final
model
signific
predictor
signific
level
set
p
fiftythre
children
asthma
enrol
surveil
sampl
collect
septemb
august
sick
sampl
collect
decemb
august
subject
predominantli
africanamerican
tabl
subject
atop
expos
tobacco
smoke
household
incom
less
base
symptom
frequenc
report
inhal
steroid
use
children
mild
intermitt
mild
persist
asthma
approxim
onequart
moderatetosever
persist
diseas
use
inhal
corticosteroid
within
last
year
note
commun
high
rate
poorli
control
asthma
undertreat
inhal
corticosteroid
mean
valu
forc
vital
capac
fvc
fev
pef
measur
time
first
surveil
visit
normal
fev
fvc
ratio
forc
expiratori
flow
pulmonari
volum
fef
mildli
reduc
tabl
averag
feno
elev
group
mean
surveil
nasal
aspir
mrna
protein
valu
shown
tabl
septemb
august
surveil
sampl
collect
posit
virus
decemb
august
selfreport
respiratori
ill
found
sampl
collect
analysi
sampl
pool
within
individu
sick
period
show
ill
posit
viru
thu
surveil
period
virusneg
sampl
associ
symptom
score
mean
standard
deviat
sd
virusposit
sampl
associ
symptom
score
p
wilcoxon
ranksum
test
sick
period
virusneg
sampl
associ
symptom
score
virusposit
sampl
associ
symptom
score
children
virusposit
sever
ill
symptom
score
experienc
reduct
fef
fig
symptomat
virusneg
group
demonstr
signific
increas
feno
fig
next
examin
nasal
aspir
mrna
protein
level
condit
total
sampl
analyz
tabl
interest
sampl
virusposit
associ
symptom
score
asymptomat
infect
least
sampl
collect
within
day
asymptomat
infect
eighteen
preced
cold
within
time
period
indic
asymptomat
infect
repres
convalesc
earlier
symptomat
cold
compar
virusneg
asymptomat
condit
sampl
children
sever
cold
symptom
score
show
higher
nasal
mrna
express
fig
greater
protein
abund
fig
addit
sampl
children
b
figur
comparison
lung
function
exhal
eno
group
condit
virusnegativehighsymptom
group
symptom
score
black
squar
viruspositivemildsymptom
group
symptom
score
gray
squar
viruspositiveasymptomat
symptom
score
white
squar
virusnegativehighsymptom
group
symptom
score
black
circl
virusnegativemildsymptom
group
symptom
score
gray
circl
compar
virusnegativeasymptomat
group
chang
lung
function
percent
predict
compar
virusnegativelowsymptom
group
adjust
mean
estim
confid
interv
shown
b
chang
eno
ppb
compar
virusnegativenosymptom
group
adjust
odd
ratio
confid
interv
shown
sever
cold
like
detect
level
mrna
fig
sampl
children
mild
asymptomat
viral
infect
also
show
signific
increas
nasal
aspir
biomark
albeit
fewer
biomark
sampl
sever
cold
fig
sampl
children
asymptomat
infect
show
higher
nasal
mrna
protein
express
suggest
persist
cytokin
resolut
symptom
children
mild
cold
asymptomat
infect
sever
cold
also
show
increas
number
aspir
posit
ifnl
mrna
fig
final
unexpectedli
symptomat
virusneg
ill
show
signific
increas
nasal
biomark
except
protein
reexamin
data
restrict
analysi
children
persist
asthma
either
mild
moderatetosever
nearli
ident
result
obtain
except
sampl
virusposit
group
show
signific
increas
ifnl
compar
virusneg
asymptomat
condit
shown
consider
number
virusneg
ill
led
us
examin
distribut
subject
selfreport
atopi
proxim
highway
viral
detectionsymptom
score
condit
howev
differ
seen
percentag
children
atopi
x
hightraff
exposur
virusneg
ill
group
also
reevalu
data
effect
modif
use
interact
model
interact
term
atopi
high
traffic
statist
signific
final
reran
gee
model
adjust
main
effect
atopi
high
traffic
chang
seen
associ
interest
virussymptom
group
cytokin
level
rv
infect
examin
associ
viral
copi
number
nasal
aspir
mrna
protein
overal
symptom
score
nasal
aspir
rv
copi
number
posit
associ
mrna
express
fig
viral
load
also
associ
protein
abund
fig
togeth
attract
neutrophil
monocyt
airway
howev
level
promot
eosinophil
chemotaxi
allerg
airway
diseas
associ
viral
load
signific
differ
found
viral
copi
number
symptomat
asymptomat
infect
symptomat
copiesml
asymptomat
copiesml
geometr
mean
geometr
sd
p
wilcoxon
rank
sum
test
associ
seen
viral
copi
number
overal
symptom
score
p
studi
statist
power
correl
copi
number
lung
function
although
design
studi
examin
time
cours
cytokin
express
collect
includ
sampl
sick
period
singl
viral
infect
well
baselin
surveil
sampl
individu
messeng
rna
express
protein
abund
peak
day
onset
infect
fig
protein
abund
peak
day
b
c
figur
comparison
nasal
aspir
mrna
protein
group
condit
virusnegativehighsymptom
group
symptom
score
black
squar
viruspositivemildsymptom
group
symptom
score
gray
squar
viruspositiveasymptomat
symptom
score
white
squar
virusnegativehighsymptom
group
symptom
score
black
circl
virusnegativemildsymptom
group
symptom
score
gray
circl
compar
virusnegativeasymptomat
group
differ
log
transform
mean
mrna
valu
rigi
compar
virusnegativelowsymptom
group
confid
interv
also
shown
p
b
mrna
analyz
binari
variabl
detect
undetect
odd
ratio
confid
interv
compar
virusnegativelowsymptom
group
shown
p
c
differ
logtransform
mean
mrna
valu
compar
virusnegativelowsymptom
group
confid
interv
also
shown
p
abbrevi
ccl
cc
motif
chemokin
ligand
cxcl
cxc
motif
chemokin
ligand
interferon
il
interleukin
interferon
regulatori
melanoma
differentiationassoci
protein
mrna
messeng
rna
rigi
retinoicacidinduc
protein
sicam
solubl
intercellular
adhes
molecul
tolllik
receptor
fig
promot
type
inflamm
peak
day
infect
studi
undertaken
examin
influenc
natur
upper
respiratori
tract
viral
infect
respiratori
symptom
airway
function
inflamm
children
asthma
urban
commun
determin
possibl
mechan
correl
outcom
nasal
aspir
cytokin
biomark
hypothes
children
highsymptom
sever
cold
greater
airflow
obstruct
respiratori
tract
inflamm
viral
copi
number
milder
cold
asymptomat
infect
well
virusneg
condit
contrast
children
suburban
set
highsymptom
viral
infect
associ
reduc
small
airway
function
evidenc
chang
fef
compar
virusneg
asymptomat
condit
children
sever
cold
show
elev
nasal
mrna
protein
biomark
children
mild
asymptomat
infect
show
fewer
elev
found
associ
viral
load
nasal
aspir
level
chemokin
togeth
attract
neutrophil
monocyt
airway
promot
eosinophil
chemotaxi
allerg
airway
diseas
first
studi
correl
viral
load
respiratori
tract
cytokin
level
natur
cold
final
urban
children
asthma
experienc
mani
virusneg
symptomat
ill
associ
increas
exhal
nitric
oxid
reduc
airway
function
elev
nasal
biomark
found
subject
slightli
like
viru
selfreport
cold
surveil
sampl
collect
high
rate
viral
detect
surveil
period
consist
previou
studi
well
children
asthma
unlik
attribut
fals
posit
rv
detect
confirm
amplif
sequenc
gelpurifi
pcr
product
case
convers
believ
low
viral
detect
rate
symptomat
episod
explain
fact
sampl
collect
fall
instead
collect
januari
august
rhinoviru
infect
less
preval
low
symptom
threshold
sick
sampl
collect
financi
reimburs
sick
period
assess
offset
time
effort
need
particip
could
also
contribut
low
viral
detect
rate
rate
viral
detect
lower
report
previous
consist
lower
frequenc
viral
detect
urban
children
respiratori
ill
compar
suburban
children
final
data
indic
urban
children
asthma
experi
frequent
virusneg
upper
respiratori
tract
ill
coldlik
ill
unlik
repres
falseneg
viral
infect
unaccompani
reduc
pulmonari
function
increas
nasal
aspir
doublestrand
rna
pattern
recognit
receptor
increas
virusposit
sampl
shown
induc
rv
infect
final
retest
subset
initi
multiplex
pcr
viral
detect
result
use
standard
rv
qpcr
found
falseneg
rate
previou
studi
rv
common
viru
detect
overal
innerc
infant
low
rate
viral
detect
howev
appreci
higher
adenoviru
rate
observ
previous
although
rvc
associ
sever
asthma
exacerb
recruit
enough
patient
discern
differ
symptom
sever
speci
next
evalu
signific
viral
infect
respiratori
symptom
lung
function
respiratori
tract
inflamm
one
third
viral
infect
associ
sever
cold
symptom
score
definit
includ
children
wheez
difficulti
breath
breath
fast
contrast
children
asthma
suburb
sydney
children
detroit
sever
cold
demonstr
signific
reduct
fef
consist
small
airway
involv
discrep
could
relat
frequent
undertreat
urban
children
asthma
inhal
corticosteroid
use
reduc
rate
exacerb
urban
children
may
suscept
viralinduc
reduct
airway
function
suburban
children
hypothesi
consist
previou
studi
impact
pollut
asthma
seen
predominantli
children
use
steroid
addit
found
highsymptom
sever
viral
infect
virusneg
ill
associ
signific
elev
nasal
aspir
mrna
express
protein
abund
previou
studi
children
natur
cold
shown
increas
nasal
chemokin
increas
noteworthi
function
receptor
rv
melanoma
differentiationassoci
protein
cytoplasm
endosom
receptor
viral
doublestrand
rna
respect
wherea
receptor
major
group
rv
sampl
children
mild
asymptomat
viral
infect
also
show
signific
increas
nasal
aspir
biomark
albeit
fewer
sampl
sever
cold
one
fourth
b
c
figur
associ
nasal
aspir
biomark
rhinovir
rna
nasal
aspir
mrna
repres
ln
mrna
adjust
mean
confid
interv
shown
b
nasal
aspir
protein
repres
ln
protein
level
adjust
mean
confid
interv
shown
associ
viral
copi
number
nasal
biomark
determin
use
gee
method
p
cg
individu
adjust
correl
viral
copi
number
select
nasal
aspir
cytokin
abbrevi
gee
gener
estim
equat
mrna
messeng
rna
virusposit
sampl
associ
symptom
collect
sampl
often
follow
symptomat
viral
infect
indic
asymptomat
infect
repres
convalesc
sever
cold
sampl
children
asymptomat
infect
show
higher
nasal
mrna
protein
express
suggest
persist
cytokin
resolut
symptom
hypothes
viral
copi
number
determin
asthma
symptom
respiratori
tract
inflamm
rv
infect
found
viral
load
associ
protein
abund
chemokin
togeth
attract
neutrophil
monocyt
airway
cytokin
promot
eosinophil
chemotaxi
allerg
airway
diseas
contrast
associ
seen
viral
copi
number
symptom
data
consist
previou
studi
adult
asthma
show
correl
sever
lower
respiratori
tract
symptom
viral
load
data
suggest
respiratori
symptom
children
asthma
natur
cold
may
depend
viral
load
alon
factor
may
determin
asthma
control
viral
infect
includ
environment
genet
factor
exact
natur
observ
virusneg
respiratori
tract
ill
unclear
unlik
virusposit
ill
virusneg
symptomat
sick
accompani
increas
eno
previou
studi
subject
asthma
shown
experiment
exposur
allergen
particul
matter
increas
eno
contrast
experiment
rv
infect
suggest
virusneg
ill
could
precipit
environment
exposur
find
associ
viralneg
ill
selfreport
atopi
proxim
hightraff
roadway
howev
group
studi
repres
differ
subject
differ
diseas
state
accord
viral
detect
symptom
possibl
ill
repres
acut
exposur
allergen
traffic
pollut
african
american
children
live
lowsocioeconomicstatu
urban
environ
continu
experi
higher
asthma
morbid
white
children
racial
dispar
observ
asthma
preval
emerg
depart
visit
hospit
readmiss
death
rate
therefor
although
data
detroit
may
generaliz
set
provid
new
insight
effect
viral
infect
import
pediatr
popul
studi
number
limit
first
use
nasal
aspir
sampl
respiratori
tract
inflamm
allow
repeat
collect
sampl
children
noninvas
manner
valid
method
compar
result
lower
respiratori
tract
specimen
howev
gene
express
among
children
asthma
alter
similarli
nasal
bronchial
airway
second
lag
period
occur
onset
respiratori
symptom
nasal
aspir
collect
third
symptom
may
caus
prevent
number
unmeasur
covari
includ
bodi
mass
index
mucu
product
antiinflammatori
cytokin
fourth
assess
symptom
score
asthma
sever
atopi
base
selfreport
independ
valid
allow
possibl
measur
error
conclud
urban
children
chronic
asthma
highsymptom
respiratori
viral
infect
reduc
airway
function
children
sever
cold
demonstr
elev
nasal
biomark
children
mild
cold
asymptomat
infect
virusneg
ill
howev
mani
children
experienc
virusneg
coldlik
ill
associ
increas
eno
nasal
aspir
biomark
lung
function
chang
studi
need
understand
precis
factor
determin
respiratori
tract
symptom
children
asthma
runni
nose
stuffi
nose
sore
throat
durat
ill
day
wheez
difficulti
breath
breath
fast
go
school
usual
activ
total
score
sum
report
compon
